印度早期使用本拉利祖马布的经验 - 关于严重喘病例的汇编:一个病例系列
Deepak Talwar1, Manoj Yadav2, Nagarjuna Maturu3
1Pulmonology and Sleep Medicine, Metro Hospitals and Heart Institute, Noida, Uttar Pradesh, 201301, India.
F1000Research
|March 4, 2024
概括
贝纳利祖马布在印度患者中有效治疗严重的酸性喘 (SEA),减少恶化和口服皮质类固醇的使用,同时改善肺功能和生活质量.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的乙酸性喘 (severe eosinophilic asthma,简称SEA) 是一种由高乙酸细胞数量标志着喘的表型,导致症状不受控制,频繁恶化,并降低生活质量.
- 尽管最佳的吸入器治疗,患者SEA经常经历持续的症状和肺功能差.
- 单克隆抗体本拉利祖马布 (benralizumab) 已被批准用于管理SEA.
研究的目的:
- 为了呈现第一个真实世界的证据,证明本拉利祖马布在印度患者中具有严重的酸性喘的有效性.
- 在一系列6个SEA病例中评估本拉利祖马布治疗的临床和功能结果.
主要方法:
- 六名被诊断患有SEA的患者接受了本拉利祖马布30毫克.
- 治疗包括每四周一次给药,用于前三剂,然后每八周一次,持续两年.
- 终点包括IgE重叠,恶化的减少,口服皮质类固醇的戒断,以及肺功能和生活质量的改善.
主要成果:
- 所有六名患者在本拉利祖马布治疗后都经历了最佳的临床和功能改善.
- 在所有案例中都观察到系统性类固醇使用的显著下降.
- 患者在治疗后报告生活质量和肺功能有所改善.
结论:
- 本案例系列提供了第一个关于印度海域人口中本拉利祖马布的现实数据.
- 所有患者都表现出显著的症状改善,减轻了恶化,并减少了对口服皮质类固醇的依赖.
- 在印度,本拉利祖马布在治疗严重的酸性喘方面显示出显著的前景.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:20Asthma: Pathogenesis and Management
396
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
264
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
264